# Serina Therapeutics, Inc. (SER)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SER/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -6.94M | $ -4.57M | N/A | $ 17.63M |
| 2025 | $ 133.1K | $ -19.64M | $ -18.40M | $ 3.14M | $ -37.0K |
| 2024 | $ 5.3K | $ -11.71M | $ -18.04M | $ 268.0K | $ 641.0K |
| 2023 | $ 3.41M | $ 5.70M | $ -3.22M | $ 3.70M | $ 4.11M |
| 2022 | $ 38.0K | $ -11.69M | $ -6.63M | $ 18.12M | $ -17.21M |
| 2021 | $ 141.4K | $ -10.31M | $ -9.34M | $ 13.20M | $ -11.83M |
| 2020 | $ 2.38M | $ -13.84M | $ -9.98M | $ 6.30M | $ -5.12M |
| 2019 | $ 1.73M | $ -15.69M | $ -13.94M | $ 1.96M | $ 2.22M |
| 2018 | $ 1.84M | $ -9.91M | $ -10.59M | $ 0 | $ 7.45M |
| 2017 | $ 1.89M | $ -8.86M | $ -8.47M | $ 0 | $ 7.28M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.55 |
| Current Ratio | 4.18 |

## Other views

- [Metrics](https://sponda.capital/en/SER.md)
- [Charts](https://sponda.capital/en/SER/charts.md)
- [Compare](https://sponda.capital/en/SER/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.